Inventor · disambiguated record
Douglas J. Jolly
Also filed as: JOLLY DOUGLAS · JOLLY DOUGLAS J
53 granted patents·22 pending applications·3,170 citations·filing 1993–2021
99Inventor score
Top patents by PatentIndex Score
75 records- 0199US5814482AEukaryotic layered vector initiation systemsFiled 1996·Granted Sep 29, 1998·536 cites·25 claims
- 0298US6015686AEukaryotic layered vector initiation systemsVIAGENE INC·Filed 1995·Granted Jan 18, 2000·253 cites·20 claims
- 0398US5843723AAlphavirus vector constructsCHIRON CORP·Filed 1996·Granted Dec 1, 1998·327 cites·47 claims
- 0498US5789245AAlphavirus structural protein expression cassettesCHIRON CORP·Filed 1996·Granted Aug 4, 1998·345 cites·29 claims
- 0597US7977091B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2009·Granted Jul 12, 2011·38 cites·4 claims
- 0696US6015694AMethod for stimulating an immune response utilizing recombinant alphavirus particlesCHIRON CORP·Filed 1997·Granted Jan 18, 2000·228 cites·11 claims
- 0795US5716826ARecombinant retrovirusesVIAGENE INC·Filed 1993·Granted Feb 10, 1998·116 cites·8 claims
- 0895US5716613ARecombinant retrovirusesVIAGENE INC·Filed 1995·Granted Feb 10, 1998·120 cites·7 claims
- 0994US5591624ARetroviral packaging cell linesVIAGENE INC·Filed 1993·Granted Jan 7, 1997·217 cites·9 claims
- 1093US7070994B2Packaging cellsOXFORD BIOMEDICA LTD·Filed 2002·Granted Jul 4, 2006·46 cites·5 claims
- 1192US5851529ARecombinant retrovirusesFiled 1995·Granted Dec 22, 1998·85 cites·16 claims
- 1291US6730297B1Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disordersCHIRON CORP·Filed 2000·Granted May 4, 2004·41 cites·13 claims
- 1389US5691177ARecombinant retroviruses expressing a protein that converts a pro-drug into a cytotoxic agentFiled 1995·Granted Nov 25, 1997·62 cites·24 claims
- 1488US7572628B2Eukaryotic layered vector initiation systemsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Aug 11, 2009·9 cites·34 claims
- 1588US5888502ARecombinant retrovirusesFiled 1995·Granted Mar 30, 1999·57 cites·72 claims
- 1688US5817491AVSV G pseusdotyped retroviral vectorsUNIV CALIFORNIA·Filed 1994·Granted Oct 6, 1998·135 cites·22 claims
- 1787US8829173B2Recombinant vectorsGRUBER HARRY E·Filed 2011·Granted Sep 9, 2014·8 cites·33 claims
- 1886US9669049B2Compositions comprising gamma retrovirus vectors and methods of treating proliferative disordersGRUBER HARRY E·Filed 2011·Granted Jun 6, 2017·6 cites·27 claims
- 1986US6818439B1Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disordersCHIRON CORP·Filed 1997·Granted Nov 16, 2004·92 cites·20 claims
- 2086US5716832APackaging cellsVIAGENE INC·Filed 1995·Granted Feb 10, 1998·63 cites·11 claims
- 2186US5693522AAnti-cancer immunotherapeuticsVIAGENE INC·Filed 1995·Granted Dec 2, 1997·70 cites·20 claims
- 2285US8722867B2Gene therapy vectors and cytosine deaminasesGRUBER HARRY E·Filed 2011·Granted May 13, 2014·7 cites·44 claims
- 2384US9320738B2Formulations of 5-fluorocytosine and uses thereofGRUBER HARRY E·Filed 2009·Granted Apr 26, 2016·5 cites·68 claims
- 2481US9732326B2Recombinant vectorsTOCAGEN INC·Filed 2014·Granted Aug 15, 2017·3 cites·24 claims
- 2580US11230719B2Retroviral vector having immune-stimulating activityDENOVO BIOPHARMA LLC·Filed 2015·Granted Jan 25, 2022·2 cites·11 claims
- 2679US10035983B2Gene therapy vectors and cytosine deaminasesTOCAGEN INC·Filed 2014·Granted Jul 31, 2018·3 cites·6 claims
- 2779US5997859AMethod for treating a metastatic carcinoma using a conditionally lethal geneCHIRON CORP·Filed 1995·Granted Dec 7, 1999·46 cites·19 claims
- 2878US11279949B2Recombinant vectors comprising 2A peptideDENOVO BIOPHARMA LLC·Filed 2016·Granted Mar 22, 2022·3 cites·22 claims
- 2977US11065311B2Retroviral vector with mini-promoter cassetteDENOVO BIOPHARMA LLC·Filed 2013·Granted Jul 20, 2021·2 cites·40 claims
- 3076US11191764B2Formulations of 5-fluorocytosine and uses thereofDENOVO BIOPHARMA LLC·Filed 2019·Granted Dec 7, 2021·0 cites·18 claims
- 3175US5662896ACompositions and methods for cancer immunotherapyVIAGENE INC·Filed 1993·Granted Sep 2, 1997·36 cites·4 claims
- 3275US2020239858A1Recombinant vectorsTOCAGEN INC·Filed 2019·Application pending·0 cites
- 3374US9889133B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2016·Granted Feb 13, 2018·1 cites·18 claims
- 3474US9663834B2Retrovirus detectionJOLLY DOUGLAS J·Filed 2011·Granted May 30, 2017·1 cites·30 claims
- 3573US9642921B2Cancer combination therapy and recombinant vectorsTOCAGEN INC·Filed 2013·Granted May 9, 2017·1 cites·14 claims
- 3673US6855549B1Methods and compositions for increasing the infectivity of gene transfer vectorsUNIV IOWA RES FOUND·Filed 1999·Granted Feb 15, 2005·34 cites·34 claims
- 3772US5856185AMethod for making reflection defective retroviral vectors for infecting human cellsCHIRON CORP·Filed 1995·Granted Jan 5, 1999·32 cites·18 claims
- 3870US7034010B2Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disordersUNIV IOWA RES FOUND·Filed 2003·Granted Apr 25, 2006·2 cites·5 claims
- 3968US5830458AMethod for destroying a diseased human cellFiled 1995·Granted Nov 3, 1998·19 cites·38 claims
- 4065US6297048B1Hepatitis therapeuticsCHIRON CORP·Filed 1995·Granted Oct 2, 2001·29 cites·7 claims
- 4165US6133029AReplication defective viral vectors for infecting human cellsCHIRON CORP·Filed 1995·Granted Oct 17, 2000·21 cites·8 claims
- 4264US6241982B1Method for treating brain cancer with a conditionally lethal geneCHIRON CORP·Filed 1995·Granted Jun 5, 2001·12 cites·34 claims
- 4364US2022195460A1Retroviral vector having immune-stimulating activityDENOVO BIOPHARMA LLC·Filed 2021·Application pending·0 cites
- 4463US10449194B2Formulations of 5-fluorocytosine and uses thereofTOCAGEN INC·Filed 2018·Granted Oct 22, 2019·0 cites·13 claims
- 4562US10407666B2Recombinant vectorsTOCAGEN INC·Filed 2017·Granted Sep 10, 2019·0 cites·10 claims
- 4662US2021361691A1Enhanced cancer treatment and monitoring using recombinant vectorsDENOVO BIOPHARMA LLC·Filed 2021·Application pending·0 cites
- 4761US2004029278A1Eukaryotic layered vector initiation systemsCHIRON CORP·Filed 2002·Application pending·0 cites
- 4859US11060112B2Producer cells for replication competent retroviral vectorsDENOVO BIOPHARMA LLC·Filed 2019·Granted Jul 13, 2021·0 cites·12 claims
- 4957US2018021365A1Enhanced cancer treatment and monitoring using recombinant vectorsTOCAGEN INC·Filed 2017·Application pending·0 cites
- 5056US5698446AMethods and compositions for inhibiting production of replication competent virusCHIRON CORP·Filed 1994·Granted Dec 16, 1997·17 cites·25 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →